These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 38098230

  • 41. Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment.
    Petty AJ, Li A, Wang X, Dai R, Heyman B, Hsu D, Huang X, Yang Y.
    J Clin Invest; 2019 Dec 02; 129(12):5151-5162. PubMed ID: 31638600
    [Abstract] [Full Text] [Related]

  • 42. C5a receptor (CD88) promotes motility and invasiveness of gastric cancer by activating RhoA.
    Kaida T, Nitta H, Kitano Y, Yamamura K, Arima K, Izumi D, Higashi T, Kurashige J, Imai K, Hayashi H, Iwatsuki M, Ishimoto T, Hashimoto D, Yamashita Y, Chikamoto A, Imanura T, Ishiko T, Beppu T, Baba H.
    Oncotarget; 2016 Dec 20; 7(51):84798-84809. PubMed ID: 27756879
    [Abstract] [Full Text] [Related]

  • 43. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.
    Zhang QF, Li J, Jiang K, Wang R, Ge JL, Yang H, Liu SJ, Jia LT, Wang L, Chen BL.
    Theranostics; 2020 Dec 20; 10(23):10619-10633. PubMed ID: 32929370
    [Abstract] [Full Text] [Related]

  • 44. The complement anaphylatoxin C5a receptor contributes to obese adipose tissue inflammation and insulin resistance.
    Phieler J, Chung KJ, Chatzigeorgiou A, Klotzsche-von Ameln A, Garcia-Martin R, Sprott D, Moisidou M, Tzanavari T, Ludwig B, Baraban E, Ehrhart-Bornstein M, Bornstein SR, Mziaut H, Solimena M, Karalis KP, Economopoulou M, Lambris JD, Chavakis T.
    J Immunol; 2013 Oct 15; 191(8):4367-74. PubMed ID: 24043887
    [Abstract] [Full Text] [Related]

  • 45. Total glucosides of paeony inhibit breast cancer growth by inhibiting TAMs infiltration through NF-κB/CCL2 signaling.
    Jin L, Guo Y, Mao W, Wang J, Jin L, Liu X, Shou Q, Fu H.
    Phytomedicine; 2022 Sep 15; 104():154307. PubMed ID: 35841664
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer.
    Yang M, Lu J, Zhang G, Wang Y, He M, Xu Q, Xu C, Liu H.
    J Immunother Cancer; 2021 Jan 15; 9(1):. PubMed ID: 33452206
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways.
    Maeda Y, Kawano Y, Wada Y, Yatsuda J, Motoshima T, Murakami Y, Kikuchi K, Imamura T, Eto M.
    Oncol Rep; 2015 Apr 15; 33(4):1844-50. PubMed ID: 25682807
    [Abstract] [Full Text] [Related]

  • 50. Engineered Bacterial Biomimetic Vesicles Reprogram Tumor-Associated Macrophages and Remodel Tumor Microenvironment to Promote Innate and Adaptive Antitumor Immune Responses.
    Zheng P, He J, Fu Y, Yang Y, Li S, Duan B, Yang Y, Hu Y, Yang Z, Wang M, Liu Q, Zheng X, Hua L, Li W, Li D, Ding Y, Yang X, Bai H, Long Q, Huang W, Ma Y.
    ACS Nano; 2024 Mar 05; 18(9):6863-6886. PubMed ID: 38386537
    [Abstract] [Full Text] [Related]

  • 51. LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy.
    Pascual-García M, Bonfill-Teixidor E, Planas-Rigol E, Rubio-Perez C, Iurlaro R, Arias A, Cuartas I, Sala-Hojman A, Escudero L, Martínez-Ricarte F, Huber-Ruano I, Nuciforo P, Pedrosa L, Marques C, Braña I, Garralda E, Vieito M, Squatrito M, Pineda E, Graus F, Espejo C, Sahuquillo J, Tabernero J, Seoane J.
    Nat Commun; 2019 Jun 11; 10(1):2416. PubMed ID: 31186412
    [Abstract] [Full Text] [Related]

  • 52. Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver Cancer.
    Wu Q, Zhou W, Yin S, Zhou Y, Chen T, Qian J, Su R, Hong L, Lu H, Zhang F, Xie H, Zhou L, Zheng S.
    Hepatology; 2019 Jul 11; 70(1):198-214. PubMed ID: 30810243
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Hedgehog-induced PD-L1 on tumor-associated macrophages is critical for suppression of tumor-infiltrating CD8+ T cell function.
    Petty AJ, Dai R, Lapalombella R, Baiocchi RA, Benson DM, Li Z, Huang X, Yang Y.
    JCI Insight; 2021 Mar 22; 6(6):. PubMed ID: 33749663
    [Abstract] [Full Text] [Related]

  • 56. Blockage of L2HGDH-mediated S-2HG catabolism orchestrates macrophage polarization to elicit antitumor immunity.
    Feng S, Wang D, Jin Y, Huang S, Liang T, Sun W, Du X, Zhuo L, Shan C, Zhang W, Jing T, Zhao S, Hong R, You L, Liu G, Chen L, Ye D, Li X, Yang Y.
    Cell Rep; 2024 Jun 25; 43(6):114300. PubMed ID: 38829739
    [Abstract] [Full Text] [Related]

  • 57. Aiduqing formula inhibits breast cancer metastasis by suppressing TAM/CXCL1-induced Treg differentiation and infiltration.
    Li J, Wang S, Wang N, Zheng Y, Yang B, Wang X, Zhang J, Pan B, Wang Z.
    Cell Commun Signal; 2021 Aug 30; 19(1):89. PubMed ID: 34461944
    [Abstract] [Full Text] [Related]

  • 58. CCRL2 promotes antitumor T-cell immunity via amplifying TLR4-mediated immunostimulatory macrophage activation.
    Yin W, Li Y, Song Y, Zhang J, Wu C, Chen Y, Miao Y, Lin C, Lin Y, Yan D, Chen J, He R.
    Proc Natl Acad Sci U S A; 2021 Apr 20; 118(16):. PubMed ID: 33846258
    [Abstract] [Full Text] [Related]

  • 59. C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma.
    Nabizadeh JA, Manthey HD, Panagides N, Steyn FJ, Lee JD, Li XX, Akhir FNM, Chen W, Boyle GM, Taylor SM, Woodruff TM, Rolfe BE.
    FASEB J; 2019 Oct 20; 33(10):11060-11071. PubMed ID: 31298935
    [Abstract] [Full Text] [Related]

  • 60. CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer.
    Lim RJ, Salehi-Rad R, Tran LM, Oh MS, Dumitras C, Crosson WP, Li R, Patel TS, Man S, Yean CE, Abascal J, Huang Z, Ong SL, Krysan K, Dubinett SM, Liu B.
    Cell Rep Med; 2024 Apr 16; 5(4):101479. PubMed ID: 38518770
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.